<?xml version="1.0" encoding="UTF-8"?>
<ref id="B2-antioxidants-09-01083">
 <label>2.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Thomas</surname>
    <given-names>D.X.</given-names>
   </name>
   <name>
    <surname>Bajaj</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>McRae-McKee</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hadjichrysanthou</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Collinge</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimerâ€™s disease neuropathology</article-title>
  <source>Sci. Rep.</source>
  <year>2020</year>
  <volume>10</volume>
  <fpage>14579</fpage>
  <pub-id pub-id-type="doi">10.1038/s41598-020-71305-2</pub-id>
  <pub-id pub-id-type="pmid">32883971</pub-id>
 </element-citation>
</ref>
